Cross-Neutralizing Antibodies Bind a SARS-CoV-2 Cryptic Site and Resist Circulating Variants

Investigators obtained two cross-neutralizing antibodies that target Sarbecoviruses’ receptor-binding domain with sub-picomolar affinities and potently neutralize authentic SARS-CoV-2.